Misumi Yusuke, Hoashi Takaya, Kagisaki Koji, Kitano Masataka, Kurosaki Kenichi, Shiraishi Isao, Yagihara Toshikatsu, Ichikawa Hajime
Department of Pediatric Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Interact Cardiovasc Thorac Surg. 2014 Mar;18(3):259-65. doi: 10.1093/icvts/ivt508. Epub 2013 Dec 12.
Common atrioventricular valve (CAVV) regurgitation is widely known as a risk factor for mortality and Fontan completion in patients with functional single ventricle. Hence, we reviewed our surgical experience with CAVV plasty in Fontan candidates.
Staged Fontan strategy and extracardiac total cavopulmonary connection as Fontan modification were our principal approaches in 1995. Since then, 38 consecutive Fontan candidates (21 males, median weight at operation was 7.0 kg and median age was 17 months old) underwent CAVV plasty. Right atrial isomerism was associated with 24 patients. The initial CAVV plasty was performed before inter-stage bidirectional Glenn (BDG) in 3 patients, at BDG in 23, before Fontan in 4 and during Fontan in 8. Since 1995, the modified Alfieri technique with a tailed, expanded, polytetrafluoroethylene tube as a bridging strip was the procedure for repair and 27 patients underwent the procedure. The mean follow-up period was 7.1 years (range 0-17 years).
Actuarial survival and freedom from CAVV replacement rates at 1, 5 and 10 years were 81, 70 and 67% and 89, 85 and 75%, respectively. Seven patients ultimately underwent CAVV replacement with one death. Twenty-three of the 38 patients completed Fontan operation (61%). Association with total anomalous pulmonary venous connection (P= 0.01) and CAVV plasty before BDG (P= 0.05) were risk factors for mortality.
CAVV plasty for patients with functional single ventricle is still challenging; however, the aggressive and repeated surgical intervention may contribute to provide better life-prognosis. The ventricular volume unloading effect of BDG without additional pulmonary blood flow or Fontan operation did not contribute to maintain CAVV function. Therefore, there would not be any hesitation for CAVV replacement to control CAVVR in the setting of systemic ventricular failure. Although the statistically significant therapeutic superiority of the modified Alfieri technique was not shown so far, further follow-up may reveal the advantage of this easy and simple technique.
共同房室瓣(CAVV)反流是功能性单心室患者死亡和Fontan手术成功的一个众所周知的危险因素。因此,我们回顾了我们在Fontan手术候选患者中进行CAVV成形术的手术经验。
1995年,分期Fontan策略和作为Fontan改良术的体外全腔静脉肺动脉连接是我们的主要手术方法。从那时起,38例连续的Fontan手术候选患者(21例男性,手术时中位体重为7.0 kg,中位年龄为17个月)接受了CAVV成形术。24例患者合并右心房异构。3例患者在分期双向格林(BDG)手术前进行了初次CAVV成形术,23例在BDG手术时进行,4例在Fontan手术前进行,8例在Fontan手术期间进行。自1995年以来,采用带尾、扩张的聚四氟乙烯管作为桥接条的改良Alfieri技术进行修复,27例患者接受了该手术。平均随访期为7.1年(范围0 - 17年)。
1年、5年和10年的精算生存率以及免于CAVV置换率分别为81%、70%和67%以及89%、85%和75%。7例患者最终接受了CAVV置换,1例死亡。38例患者中有23例完成了Fontan手术(61%)。合并完全性肺静脉异位连接(P = 0.01)和BDG手术前进行CAVV成形术(P = 0.05)是死亡的危险因素。
功能性单心室患者的CAVV成形术仍然具有挑战性;然而,积极且反复的手术干预可能有助于改善生活预后。BDG手术在无额外肺血流或Fontan手术情况下的心室容量卸载效应无助于维持CAVV功能。因此,在系统性心室功能衰竭的情况下,对于控制CAVV反流进行CAVV置换不应有任何犹豫。尽管到目前为止改良Alfieri技术在统计学上的显著治疗优势尚未显现,但进一步随访可能会揭示这种简单技术的优势。